-
2 days ago | 
medicalxpress.com | Claire Kowalick
A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to optimize the capacity of drug-delivery into these cells.
-
3 days ago | 
news.uthscsa.edu | Claire Kowalick
The ability of macrophages, a type of white blood cell, to transition into one of two forms, is critical for immune system functionality. These cells can morph into fighter cells (M1) that cause inflammation and attack invading pathogens, or nurse cells (M2) that soothe the inflammation and promote tissue repair after the battle. While researchers have known macrophages pivot to perform these functions, how this process occurs is not fully understood.
-
6 days ago | 
news.uthscsa.edu | Claire Kowalick
Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), together with two other teams led by Hui-kuan Lin, PhD, from Duke...
-
2 weeks ago | 
news.uthscsa.edu | Claire Kowalick
This story is featured in the April 2025 Bexar County Medical Society’s San Antonio Medicine magazineAbout one in 10 Texans is living with Type 2 diabetes — one of the highest rates of the disease in the United States. In San Antonio, the rate is one in six people and another third of the population is prediabetic, according to the American Diabetes Association.
-
4 weeks ago | 
news.uthscsa.edu | Claire Kowalick
An ancient movement technique is merging with cutting-edge technology in a novel study at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) aimed at preventing falls in people with Alzheimer’s disease and related dementias.
-
1 month ago | 
news.uthscsa.edu | Claire Kowalick
Sylvia Botros-Brey, MD, MSCI, professor of urology, obstetrics and gynecology, and medical education at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was selected for a Catalyst Award for Transformation in Graduate Medical Education from the Josiah Macy Jr. Foundation and Accreditation Council for Graduate Medical Education.
-
1 month ago | 
medicalxpress.com | Claire Kowalick
San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or cirrhosis and liver cancer, posing a significant public health challenge.
-
1 month ago | 
news.uthscsa.edu | Claire Kowalick
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has undergone a remarkable transformation over the past decade, marked by growth across every facet of its mission. This momentum is reflected in the latest rankings from the Blue Ridge Institute for Medical Research, an independent nonprofit that compiles annual National Institutes of Health (NIH) funding reports.
-
1 month ago | 
medicalxpress.com | Claire Kowalick
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that can treat all types of AML.
-
1 month ago | 
news.uthscsa.edu | Claire Kowalick
San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or cirrhosis and liver cancer, posing a significant public health challenge.
